Receptos to Present at Upcoming Investor Conferences
August 08 2013 - 7:00AM
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company
developing therapeutic candidates for the treatment of immune and
metabolic diseases, today announced that management will be
presenting at two upcoming investor conferences. The details are as
follows:
Wedbush Life Sciences Management Access
Conference |
Hotel: Le Parker Meridien Hotel in New York
City |
Time: Wednesday, August 14, 2013 at 8:00 a.m.
Eastern |
|
Canaccord Genuity Growth
Conference |
Hotel: Intercontinental in
Boston |
Time: Thursday, August 15, 2013 at 10:00
a.m. Eastern |
To listen to a live webcast or a replay of either presentation,
please visit the Investor Relations section of the Company's
website at www.receptos.com. A replay will be available for 7 days
after the event.
About Receptos
Receptos is a biopharmaceutical company developing therapeutic
candidates for the treatment of immune and metabolic diseases. The
Company's lead program, RPC1063, is a sphingosine 1-phosphate 1
receptor (S1P1R) small molecule modulator candidate for immune
indications, including relapsing multiple sclerosis (RMS) and
inflammatory bowel disease (IBD). The Company is also developing
RPC4046, an anti-interleukin-13 (IL-13) antibody for an
allergic/immune-mediated orphan disease, eosinophilic esophagitis
(EoE). Receptos has established expertise in high resolution
protein crystal structure determination, biology and drug discovery
for G-protein-coupled receptors (GPCRs).
CONTACT: Media and Investor Contact:
Graham K. Cooper
Chief Financial Officer, Receptos
(858) 652-5708
gcooper@receptos.com
RECEPTOS, INC. (NASDAQ:RCPT)
Historical Stock Chart
From Jun 2024 to Jul 2024
RECEPTOS, INC. (NASDAQ:RCPT)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More News Articles